

Mayim Bialik, an actress and ex-host of Jeopardy!, has talked about her experience with GLP-1 drugs, stating that one single dose of the medicine caused her gastrointestinal issues for several weeks. As stated by Bialik, she was never using the medication for weight loss purposes. In a recently released statement, she said, "I went on a weight-loss drug because a doctor told me it might help ease symptoms I've struggled with for basically my entire adult life.” She also explained when talking about her diarrhea, bloating, cramping, dehydration and even needing intravenous fluids.
GLP-1 agonists refer to drugs that were initially created for the purpose of managing blood glucose levels in people suffering from type 2 diabetes. These drugs work by mimicking glucagon-like peptide-1, an endogenously produced hormone whose main function is the regulation of insulin levels.
Among the most popular GLP-1 drugs, one can name Ozempic, Wegovy, Mounjaro, and Zepbound. Recently, these medications have become very popular due to the fact that they can significantly help with losing weight.
According to Mayim Bialik, her doctors advised her to take medication because they believe the anti-inflammatory effects of the medication will help reduce the symptoms associated with a variety of physical illnesses, such as thyroid disease, Sjögren's syndrome, connective tissue diseases, mast cell syndrome and dysautonomia. While she does wish to lose some body weight, that was not her primary goal when deciding on this medication after trying several other alternatives.
Research has proved that GLP-1 drugs result in significant weight loss. The patients end up losing up to 10-15 percent of their body mass. In the case of tirzepatide drugs, the rate has been even higher, up to 20%. Apart from this, the drugs may help with regulation of blood glucose levels, reduction in insulin resistance, as well as cholesterol and blood pressure management. Some patients have experienced a decrease in appetite along with greater satiety, thus making healthy dieting easier.
The most frequent adverse effects associated with GLP-1 drug arise at the start of therapy or whenever the dosage is raised. These adverse effects include nausea, vomiting, diarrhea, constipation, bloating, stomach pain, headache, dizziness, and fatigue.
Further investigation is also being conducted into the long-term issues that might be associated with the use of the drug. This includes the risk of muscle atrophy, decreased bone mineral density, as well as uncommon side effects like pancreatitis, gall bladder disease, and acute renal injury.
GLP-1 drugs, though they revolutionize the treatment of obesity, are considered by experts to be appropriate for all patients. Some GLP-1 drugs cost over one hundred dollars per month, and patients tend to regain weight once they stop the medication.
For more updates, join/follow our WhatsApp, Telegram and YouTube channels.